PCO4 Antibody

Potential Terminology Confusion

The term "PCO4" may represent a typographical error or misinterpretation of established antibody nomenclature:

• PCP4 Antibody: Targets Purkinje cell protein 4, a cerebellar calcium-binding protein (Atlas Antibodies ).

• PCA-1 (Purkinje Cell Cytoplasmic Antibody Type 1): Associated with paraneoplastic neurological syndromes (Mayo Clinic Labs ).

• Anti-PF4 Antibodies: Well-characterized in heparin-induced thrombocytopenia (HIT) and COVID-19 complications (Sources ).

Platelet Factor 4 (PF4)-Targeting Antibodies

Neurological Autoantibodies

• PCA-1: Marker for subacute cerebellar degeneration in gynecologic cancers .

• CRMP-5: Linked to lung cancer and thymoma-related autoimmunity .

Technical Limitations

• Commercial Antibody Databases (e.g., Antibody Society , Sino Biological ) show no "PCO4" entries.

• Structural Studies of neutralizing antibodies (e.g., SARS-CoV-2) focus on defined epitopes (Extended Data Table 1 in ).

Recommendations for Clarification

1. Verify the intended target (e.g., PCP4, PCA-1, or PF4).

2. Explore PF4 antibody research for thrombosis-related mechanisms ( ).

3. Consult paraneoplastic antibody panels for neurological associations ( ).